Archive for the ‘Pain’ Category

NORML’s mission is to move public opinion sufficiently to legalize the responsible use of marijuana by adults, and to serve as an advocate for consumers to assure they have access to high quality marijuana that is safe, convenient and affordable.

Source: NORML.org – Working to Reform Marijuana Laws – NORML.org – Working to Reform Marijuana Laws

Medical Marijuana Legalization Associated With Fewer Opioid-Related Hospitalizations

Medical Marijuana - Fewer Opioid-Related HospitalizationsSan Diego, CA: The enactment of statewide legislation permitting medical cannabis access by qualified patients is associated with a reduction in opioid-related hospitalization, according to data published online ahead of print in the journal Drug and Alcohol Dependence.

A researcher from the University of California at San Diego assessed the association between medical cannabis laws and hospitalizations related to opioid pain relievers. The author reported both immediate and longer-term reductions in opioid-related hospitalization following changes in law.

“This study demonstrated significant reductions on OPR- (opioid pain reliever) related hospitalizations associated with the implementation of medical marijuana policies. … We found reductions in OPR-related hospitalizations immediately after the year of policy implementation as well as delayed reductions in the third post-policy year.”

The author also dismissed contentions that liberalized marijuana laws were associated with any subsequent increase in marijuana-related hospital admissions, concluding: “While the interpretation of the results should remain cautious, this study suggested that medical marijuana policies were not associated with marijuana-related hospitalizations. Instead, the policies were unintendedly associated with substantial reductions in OPR related hospitalizations.”

The findings are consistent with those of other studies reporting that medical cannabis legalization is associated with lower rates of opioid abuse, mortality, and prescription drug spending.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever,” appears in Drug and Alcohol Dependence.

Israeli Cabinet Endorses Marijuana Decriminalization Plan

Israeli Marijuana Decriminalization PlanJerusalem, Israel: Israeli lawmakers have signed off on legislation decriminalizing offenses involving the possession of personal use quantities of marijuana.

Under the new policy, first and second time possession offenders will face a fine, but no criminal penalties.

“The Cabinet approval is an important step on the way to implementing the new policy that will put emphasis on explaining and treating rather than on criminal enforcement,” explained Israeli Public Security Minister Gilad Erdan.

The medical production and distribution of cannabis for medical purposes is already legally permitted in Israel as part of a program governed by the Ministry of Health. About 25,000 Israelis receive medical marijuana as part of this program.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org.

Study: CBD-Dominant Cannabis Extracts Reduce Seizure Frequency

CBD Cannabis Extracts Reduce SeizuresFalmouth, ME: The administration of whole-plant cannabis extracts rich in the cannabinoid cannabidol (CBD) is associated with reduced seizure frequency in patients with refractory epilepsy, according to data published online ahead of print in the journal Epilepsy & Behavior.

Researchers performed a retrospective chart review of the clinical records of 272 patients who were taking whole-plant CBD extracts.

Eighty-six percent of those treated observed some clinical benefit (a reduction in seizure frequency) while ten percent experienced a complete clinical response. The remaining patients were either not responsive to treatment or reported an exacerbation of seizures during therapy.

Beneficial side effects, such as improved mood, better sleep quality, and increased appetite were reported.

“The cannabinoids’ novel mechanisms of action are an attractive consideration for possible seizure control,” authors concluded. “In patients with refractory epilepsy that have a low likelihood of responding to a subsequent AED (anti-epileptic drug), a trial of artisanal cannabis formulas may be indicated.”

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “The current status of artisanal cannabis for the treatment of epilepsy in the United States,” appears in Epilepsy & Behavior. Additional data regarding the efficacy of cannabinoids as anticonvulsants appears in NORML’s library.

Pennsylvania: Auditor General Says State Lawmakers Should Regulate The Marijuana Market

Pennsylvania Should Regulate MarijuanaHarrisburg, PA: Pennsylvania’s auditor general on Monday publicly advocated for the legalization and taxation of retail marijuana sales, arguing that such a policy would bring new jobs and tax revenue to the state.

Speaking at a news conference at the state capitol, Auditor General Eugene DePasquale said: “The regulation and taxation of the marijuana train has rumbled out of the station, and it is time to add a stop in the Commonwealth of Pennsylvania. I make this recommendation because it is a more sane policy to deal with a critical issue facing the state. Other states are already taking advantage of the opportunity for massive job creation and savings from reduced arrests and criminal prosecutions. In addition, it would generate hundreds of millions of dollars each year that could help tackle Pennsylvania’s budget problems.”

However, Gov. Tom Wolf said that state lawmakers should not go forward with regulating the adult use marijuana market at this time. Instead, he expressed support for decriminalizing the possession and personal use of the plant.

For more information, please contact Justin Strekal, NORML Political Director, at (202) 483-5500 or visit: http://www.phillynorml.org/.

NORML and the NORML Foundation: 1100 H Street NW, Suite 830, Washington DC, 20005
Tel: (202) 483-5500 • Fax: (202) 483-0057 • Email: norml@norml.org

Chronic pain sufferers and those taking mental health meds would rather turn to cannabis instead of their prescribed opioid medication, according to new research.

Source: Given the choice, patients will reach for cannabis over prescribed opioids — ScienceDaily

New research suggests an avenue for developing treatments for chronic pain that harness the medicinal properties of cannabis while minimizing the threat of addiction. Therapeutics that target the endocannabinoid system might produce pain relief with fewer side effects compared with opioids.

Source: Cannabis: Non-addictive pathway to pain relief? Medicinal properties of cannabis examined — ScienceDaily

The medicinal properties of cannabidiol are quickly drawing the attention of scientists, plant-medicine lovers, dietary-supplement companies and Big Pharma.

Source: The Battle For Cannabidiol (CBD): Big Pharma VS The People | HoneyColony

Just incredible!  CBD is not psychoactive and should be in the same category as over-the-counter supplements, like herbal teas, echinacea, ginger, Valerian root, chamomile, etc.  But, because it offers medicinal help, the DEA bans it to support big phramaceutical companies.  I sure would like to see the DEA disbanded, as they’ve sucked more than a trillion dollars in tax money, and what have they accomplished?  A million people in prison, $5 heroin, and ubiquitous methamphetamine.  If a company was that effective, it would be bankrupt.  Why is Congress not chastising them and defunding them over such disingenuous ineffectiveness?

AuntieBS

Learn how cannabis can be used to help athletes recover from inflammation and pain, and hear former NFL quarterback Jake Plummer’s story.

Source: Can Cannabis Help with Inflammation for Athletes? | Leafly

Source: Compound suggests chronic pain treatment without opioid or medical marijuana side effects — ScienceDaily

Source: Opioid Companies Lobby Against Medical Marijuana | Huffington Post